Cambridge Bioscience is delighted to announce a new strategic distribution partnership with Jackson ImmunoReseach, following our recent acquisition of Stratech Scientific. This extends the availability of Jackson ImmunoReseach's high-quality secondary antibodies and immunodetection reagents to researchers and biopharma organisations across the UK and Ireland.
The partnership will provide scientists with streamlined access to their extensive range of products, including highly cross-absorbed secondary antibodies, conjugates and purified immunoglobulins designed to support applications such as immunohistochemistry, western blotting and flow cytometry.
Jackson ImmunoResearch has established itself as a leader in the development and manufacture of reliable, high-performance secondary antibodies. Through this partnership, we will offer local technical support, product expertise and customer service to ensure researchers can fully leverage Jackson ImmunoResearch’s trusted reagents.
This collaboration further strengthens Cambridge Bioscience’s commitment to supporting the UK and Ireland life science community with high quality tools that accelerate research and discovery.
Learn more about Jackson ImmunoResearch’s portfolio or contact our Jackson ImmunoResearch specialists.